Task: Answer the multiple-choice question.
Question: Which compound exhibits a -19.234% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CN1CCC(C2(O)c3ccccc3CCc3ccccc32)CC1
b. Cc1ccc(-n2c(CNC(=O)c3cccs3)nnc2SCC(=O)NO)cc1
c. COc1cccc(CNC(=O)CCC(=O)N2Cc3cccc(OC)c3Oc3ncccc32)c1OC
Answer: a. CN1CCC(C2(O)c3ccccc3CCc3ccccc32)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCC(C2(O)c3ccccc3CCc3ccccc32)CC1
CN1CCC(C2(O)c3ccccc3CCc3ccccc32)CC1
2-(1-methylpiperidin-4-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-2-ol